The mission of the Drugs for Neglected Diseases initiative (DNDi) is to develop safe, effective, and affordable new drugs for patients suffering from neglected diseases and to ensure equitable access to these drugs. DNDi believes that intellectual property (IP) rights should not pose a barrier to access to these medicines. Hence, a balanced approach to IP management is critical for effective implementation of DNDi's mission. The organization has written an IP policy that both encapsulates and articulates DNDi's approach to IP based on core principles and beliefs. The policy reflects the DNDi philosophy, vision, and mission, ensuring that its products are accessible and affordable to patients who need them most. DNDi recognizes the reality of IP and seeks to implement its humanitarian mission using best, pragmatic practices for IP management. Indeed, DNDi has already demonstrated that this is feasible, having successfully negotiated with both private and public sector institutions in order to actualize its principled mission.
Banerji, J.; Pécoul, B. Pragmatic and Principled: DNDiii&#8217;s Approach to IP Management. Chapter 17.19 In: Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices.. MIHR (Oxford, UK), PIPRA (Davis, USA), Oswaldo Cruz Foundation (Fiocruz, Rio de Janeiro, Brazil) and bioDevelopments-International Institute (Ithaca, USA), (2007) 1775-1782. ISBN 978-1-4243-2026-4